CYSB2300084 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-04-19 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2101177 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-09-06 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400282 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-10-26 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2200154 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2022-06-14 | | Gan & Lee Pharmaceuticals | | | view |
CXSS1600003 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2017-06-02 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2020-05-19 | view |
CXSL0900034 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-08-03 | view |
CYSB2400073 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-03-18 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2101163 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-08-20 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2400323 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2024-12-13 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2500062 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2025-03-22 | | Gan & Lee Pharmaceuticals | | | view |
CXSS1600004 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2017-06-02 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2018-12-05 | view |
CXSL0900033 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-08-03 | view |
CYSB2101104 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2021-06-25 | | Gan & Lee Pharmaceuticals | | | view |
CYSB2300032 | 门冬胰岛素注射液 | insulin aspart | Injection | Biological Products | Supplementary Application | 2023-02-09 | | Gan & Lee Pharmaceuticals | | | view |
CXSL1400055 | 门冬胰岛素50注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-10-11 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2016-05-19 | view |
CYSB2400288 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-11-05 | | Gan & Lee Pharmaceuticals | | | view |
CXSS1400003 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2014-12-25 | 甘李药业股份有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2018-06-28 | view |
CYSB2200124 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2022-05-31 | | Gan & Lee Pharmaceuticals | | | view |
CXSL0900036 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products(15) | New Drug Application | 2010-01-15 | 甘李药业有限公司 | Gan & Lee Pharmaceuticals | Certificate Issued | 2011-11-07 | view |
CYSB2400139 | 门冬胰岛素30注射液 | Insulin aspart protamine recombinant;insulin aspart recombinant | Injection | Biological Products | Supplementary Application | 2024-06-01 | | Gan & Lee Pharmaceuticals | | | view |